FDA.reportPublic FDA data

raxibacumab 1700 MG in 34 ML Injection

RxCUI
1366571
RxNorm name
raxibacumab 1700 MG in 34 ML Injection
Display name
raxibacumab 1700 MG in 34 ML Injection
Full name
raxibacumab 1700 MG in 34 ML Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125349raxibacumab351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f6927e91-bb46-47b3-ab66-f9d8a9d7b12araxibacumab 1700 MG in 34 ML Injection [PSN] · 34 ML raxibacumab 50 MG/ML Injection [SCD] · raxibacumab 1700 MG per 34 ML Injection [SY]34These highlights do not include all the information needed to use RAXIBACUMAB safely and effectively. See full prescribing information for RAXIBACUMAB. RAXIBACUMAB injection, for intravenous use Initial U.S. Approval: 201220260122